ALTANA BUYS US DERMATOLOGY BUSINESS FROM GLAXOSMITHKLINE

Altana AG's US unit Altana Inc said it has acquired the prescription dermatology business from GlaxoSmithKline Consumer Healthcare for an undisclosed amount. PharmaDerm, a division of Altana Inc, will manufacture and market the former GlaxoSmithKline products Aclovate, a synthetic corticosteroid, Cutivate and Temovate, both anti-inflammatories, the antibiotic Emgel and Oxistat, an anti-fungal. Altana Inc chief executive Paul McGarty said the acquisition is a 'significant step... toward achieving our goal of becoming the leading pharmaceutical company specializing in dermatology.'

Forbes (http://www.forbes.com/home/feeds/afx/2005/09/30/afx2253797.html)